The novelty of our research lies in identifying LINC01094 as a key regulator of glucose metabolism in BC, elucidating its m6A‐dependent upregulation, and dissecting its interaction with PKM2 and JMJD5 to promote a pro‐glycolytic and pro‐tumorigenic phenotype. Here, LINC01094 is linked to breast cancer.